Newscast – Page 138 – media

First Video Game Therapy Heads to FDA As Akili Touts ADHD Study Win

For the first time ever, a mobile video game used to assess and treat a disease is headed for an FDA review.
- Source: xconomy
- 490
- December 7, 2017
ADHD Attention Performance Index Company Insight video game
Cambridge’s Exonics Therapeutics Scores $40M

Exonics Therapeutics closed on a $40 million Series A financing. It was led by The Column Group.
- Source: biospace
- 534
- December 7, 2017
DMD Market Views neuromuscular Series
Weight Loss Really Can Reverse Diabetes, New Study Finds

in a paper published in the Lancet, researchers in the UK describe a landmark study in which people with diabetes went into remission—just by losing weight.
- Source: in a paper published in the Lancet, researchers in the UK describe a landmark study in which people with diabetes went into remission—just by losing weight.
- 544
- December 7, 2017
diabetes weight loss
Gallup Pakistan report

In a report by Gallup Pakistan short roundup of health infrastructure in Pakistan 2000-2015 based on Pakistan Economic Survey 2015-2016, it is mentioned that “Pakistan was unable to meet its Millennium Development Goals (MDGs) on health and ranks 149 in 188 countries in the first global assessment of countries.
- Source: pakistantoday
- 505
- December 6, 2017
health infrastructure hepatitis Market Views papillomavirus
Potential weapons for the battle against antibiotic resistance discovered

Scientists at the UNC School of Medicine have found that a bacterium can become much more or less susceptible to an antibiotic depending on the specific bacterial community in its midst.
- Source: sciencedaily
- 478
- December 6, 2017
aeruginosa antibiotics bacterium Researches
Infant CCHD deaths cut by 33% after mandatory pulse oximetry testing

Infant deaths from critical congenital heart disease (CCHD) declined by 33.4 percent in eight states that mandated pulse oximetry screening for newborns, according to a study published online Dec. 5 in JAMA.
- Source: cardiovascularbusiness
- 378
- December 6, 2017
CCHD Market Views
Neon Therapeutics Completes $106 Million Crossover Series B Financing

Neon Therapeutics, a clinical-stage immuno-oncology company developing neoantigen therapies, today announced the successful completion of an additional $36 million extension to its Series B financing which, combined with $70 million announced in January 2017, brings the total raised during this Series B crossover round to $106 million.
- Source: Businesswire
- 430
- December 6, 2017
immuno-oncology Market Views neoantigen
Novo Nordisk Receives FDA Approval of Ozempic (semaglutide) Injection For the Treatment of Adults with Type 2 Diabetes

Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) approved its New Drug Application (NDA) for OZEMPIC® (semaglutide) injection 0.5 mg or 1 mg, a once-weekly glucagon-like peptide (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.1 OZEMPIC® is administered once weekly, on the same day each week, and can be taken any time of the day, with or without meals.
- Source: medicalxpress
- 575
- December 6, 2017
diabetes FDA Novo Nordisk OZEMPIC®
Men with HPV are 20 times more likely to be reinfected after one year

The study, published December 5 in the Proceedings of the National Academy of Sciences, highlights the importance of vaccination for preventing the spread of HPV in young men before they become sexually active. Vaccination could potentially prevent reinfection in older men who have already contracted the virus.
- Source: medicalxpress
- 643
- December 6, 2017
cancer HPV Researches vaccination
CRISPR/Cas9 gene editing can be used to eliminate entire chromosomes — a Q&A

As is well known, CRISPR/Cas9 is an effective tool for gene editing, and this method has been widely used for editing genes or genomic regions by targeting specific single-guide RNA (sgRNAs). We initially planned to use the CRISPR/Cas9 system to study the biological functions of Y chromosome genes.
- Source: biomedcentral
- 590
- December 5, 2017
CAS9 chromosome CRISPR gene Researches

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.